Sandoz
Focus: Sandoz is a global generics and biosimilars company headquartered in Austria, specializing in affordable medicines across immunology, infectious diseases, neurology, cardiovascular, and respiratory indications. As a public-stage biotech firm, it maintains a diversified portfolio with significant exposure to mature topical corticosteroid products.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Sandoz
AI assessmentNot HiringNo open roles listed right now. Follow Sandoz to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 in 5yr
SERNIVO
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$5M Part DDeclining
LOE Approaching
Largest single revenue driver (24% of company revenue) but lifecycle approaching loss of exclusivity, creating significant revenue cliff risk.
Help build intelligence for Sandoz
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.